NCT00119756View on ClinicalTrials.gov

A Safety and Tolerability Study of Paliperidone Palmitate Injected in the Shoulder or the Buttock Muscle in Patients With Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

253

Participants

Timeline

Start Date

June 30, 2005

Study Completion Date

November 30, 2006

Conditions
Schizophrenia
Interventions
DRUG

paliperidone palmitate

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00119756 - A Safety and Tolerability Study of Paliperidone Palmitate Injected in the Shoulder or the Buttock Muscle in Patients With Schizophrenia | Biotech Hunter | Biotech Hunter